Lexaria Bioscience Corp.

LEXX | NASDAQ

Price Alert Chart Builder DCF Calculator

$3.45

+$0.03 (+0.88%)

Sep 22, 2026, 12:07 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Aug 30, 2025	FY 2024 Aug 30, 2024	FY 2023 Aug 30, 2023	FY 2022 Aug 30, 2022	FY 2021 Aug 30, 2021	FY 2020 Aug 30, 2020
Net Income	-11.91M	-5.81M	-6.71M	-7.38M	-4.19M	-4.08M
Depreciation & Amortization	87.83K	76.15K	145.4K	102.72K	147.6K	146.09K
Stock-Based Compensation	859.49K	492.24K	170.38K	752.59K	410.01K	1.14M
Other Working Capital	409.9K	-669.35K	-14.84K	-262.73K	-234.89K	-58.31K
Other Non-Cash Items	318.15K	174.71K	372.25K	2M	-424.66K	374.83K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	195.58K	106.56K	143.26K	-351.48K	63.53K	-194.36K
Operating Cash Flow	-10.45M	-4.96M	-5.88M	-4.88M	-3.99M	-2.62M
Capital Expenditures	-24.64K	-43.02K	-169.61K	-49.19K	-79.49K	-33.65K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	6.8K
Other Investing Acitivies	-218.37K	-145.59K	-135.86K	-131.45K	273.37K	n/a
Investing Cash Flow	-243.02K	-188.61K	-169.61K	-180.64K	193.88K	-26.84K
Debt Repayment	n/a	n/a	n/a	-44.6K	-66.69K	-13.83K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	6.11M	n/a	n/a	4.02M	n/a
Financial Cash Flow	6.05M	10.32M	1.59M	-44.6K	13.42M	2.65M
Net Cash Flow	-4.7M	5.15M	-4.46M	-5.1M	9.62M	8.6K
Free Cash Flow	-10.48M	-5M	-6.05M	-4.93M	-4.07M	-2.65M
Adj. Free Cash Flow	-11.33M	-5.49M	-6.22M	-5.68M	-4.48M	-3.79M
Maintenance CapEx	n/a	n/a	-169.61K	-49.19K	n/a	n/a
Growth CapEx	-24.64K	-43.02K	n/a	n/a	-79.49K	-33.65K
Owner Earnings	-10.45M	-4.96M	-6.05M	-4.93M	-3.99M	-2.62M